FLASHFER™ XT

FLASHFER™ XT Drops provides iron and folic acid in the most bioavailable and well-tolerated oral forms for paediatric supplementation.

Ferrous Ascorbate (providing Elemental Iron 10mg per mL): Ferrous ascorbate is a chelated iron-vitamin C complex in which ascorbic acid (Vitamin C) is covalently bound to ferrous iron. This chelation prevents the oxidation of ferrous (Fe²⁺) to ferric (Fe³⁺) iron in the GI lumen — a critical distinction because only ferrous iron is absorbed through the intestinal brush border iron transporter DMT1 (divalent metal transporter-1). By maintaining iron in the ferrous state, ferrous ascorbate achieves significantly higher bioavailability (approximately 2–3× higher than ferrous sulphate) with less oxidative GI irritation — the mechanism responsible for the nausea, constipation, and black stool associated with ferrous sulphate.

After DMT1-mediated absorption into duodenal enterocytes, iron is transferred to ferroportin for basolateral transport into the circulation, where it binds to transferrin for delivery to erythroid precursors in the bone marrow. In erythroid cells, iron is incorporated into protoporphyrin IX to form haem, which combines with globin chains to form functional haemoglobin.

Folic Acid 100mcg per mL is the synthetic, stable form of folate. After reduction to dihydrofolate and then tetrahydrofolate by dihydrofolate reductase, it becomes the active methyl-group donor required for thymidylate synthesis (DNA replication) and purine synthesis. Folate deficiency specifically impairs rapidly dividing cells — erythroid precursors, intestinal epithelium, and neural tube cells — causing megaloblastic anaemia, GI mucosal atrophy, and neural tube defects in early pregnancy.

FLASHFER™ XT Drops is indicated for iron deficiency anaemia and nutritional supplementation in the paediatric population and in pregnancy where liquid iron administration is required.

Iron Deficiency Anaemia in Infants and Children (Primary): Iron deficiency is the most prevalent nutritional deficiency globally, affecting approximately 50% of Indian children under 5 years. Premature infants (who have limited iron stores from shortened third-trimester accumulation) are particularly vulnerable. Ferrous ascorbate drops provide accurate weight-based iron dosing in infants who cannot swallow tablets.

Megaloblastic Anaemia Prevention: Combined iron + folic acid supplementation covers both iron deficiency anaemia and folate deficiency megaloblastic anaemia — often coexisting in malnourished infants and children.

Prophylactic Iron Supplementation: WHO recommends iron supplementation for all infants above 6 months in high-prevalence settings — ferrous ascorbate drops enable this at doses appropriate for infant weight.

Pregnancy (First Trimester): Liquid iron for pregnant women with significant nausea or vomiting who cannot tolerate tablets — ferrous ascorbate's superior tolerability profile makes it the preferred formulation for symptomatic first-trimester use.

Dosage and administration should be as prescribed by a qualified doctor or medical professional. Do not self-medicate. Always follow your physician's instructions regarding dose, frequency and duration of treatment.